Skiplink Navigation

Main Features

Hormone therapy could increase cancer risk

Men who undergo hormone therapy for prostate tumours have a bigger chance of developing intestinal cancer, according to a study.

Researchers at the cantonal hospital of St Gallen examined the files of 108,000 men suffering from prostate tumours in the United States from 1993 to 2002.

They concluded that patients following hormone therapy to fight the tumour had a greater risk of developing intestinal cancer.

Out of 1,000 men, 4.4 patients taking hormones developed the illness within a year compared with only 3.7 patients who weren’t taking them.

Testicular ablation, an outdated method of treating prostate cancer, is even worse, according to the study, as 6.3 patients out of 1,000 develop intestinal cancer after an ablation. and agencies


Neuer Inhalt

Horizontal Line

swissinfo EN

Teaser Join us on Facebook!

Join us on Facebook!

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters